Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 13/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.46 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.46 |
| ▸ | ITGAL | P20701 | 1/20 | 0.46 |
| ▸ | PGA5 | P0DJD9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2417390 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2412039 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2416964 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2416389 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2418114 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2416946 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2421544 | 1.00 | REN (0.47) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2417562 | 0.99 | REN (0.48) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2418628 | 0.97 | REN (0.48) | RENCTSBCTSKCA1CA2 | |
| SCHEMBL2420134 | 0.92 | REN (0.49) | RENCTSBCTSKCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2365052-B1 | pH tuneable-gellant for use in consumer product compositions | PROCTER & GAMBLE (US) | 2016-07-13 | — | — | EP | claimed |
| US-8236748-B2 | pH tuneable amido-gellant for use in consumer product compositions | THE PROCTER & GAMBLE COMPANY (US) | 2012-08-07 | — | — | US | claimed |
| US-20110224124-A1 | pH Tuneable Amido-Gellant For Use In Consumer Product Compositions | THE PROCTER & GAMBLE COMPANY | 2011-09-15 | — | — | US | claimed |
| EP-2365052-A1 | pH tuneable-gellant for use in consumer product compositions | The Procter & Gamble Company (US) | 2011-09-14 | — | — | EP | claimed |
| EP-2365052-B1 | pH tuneable-gellant for use in consumer product compositions | PROCTER & GAMBLE (US) | 2016-07-13 | — | — | EP | disclosed |
| EP-2365052-A1 | pH tuneable-gellant for use in consumer product compositions | The Procter & Gamble Company (US) | 2011-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224124-A1 | pH Tuneable Amido-Gellant For Use In Consumer Product Compositions | AGPAT2, AGPAT5, GNAO1 | REN 2577/4885CTSB 2166/4885CTSK 1752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.